SLC5A2 and hydrops fetalis: SGLT2 inhibition was also associated with higher scores of medium-chain acylcarnitines (β (95% CI), −0.80 (−1.45,–0.16)), and short-chain acylcarnitines were significantly associated with HF (HR (95% CI), 0.92 (0.86, 0.98)).